Dupilumab treatment in patients with atopic hand and foot dermatitis: results from a phase 3, randomized, double-blind, placebo-controlled trial

被引：1
|
作者：
Simpson, Eric L. [1 ]
Silverberg, Jonathan, I [2 ]
Worm, Margitta [3 ]
Honari, Golara [4 ]
Masuda, Koji [5 ]
Sygula, Ewa [6 ]
Maloney, Jennifer [7 ]
Mannent, Leda P. [8 ]
Xiao, Jing [7 ]
Dubost-Brama, Ariane [8 ]
Bansal, Ashish [7 ]
机构：
[1] Oregon Hlth & Sci Univ, Portland, OR USA
[2] George Washington Sch Med & Hlth Sci, Washington, DC USA
[3] Charite Univ Med Berlin, Berlin, Germany
[4] Stanford Univ, Sch Med, Redwood City, CA USA
[5] Kyoto Prefectural Univ Med, Kyoto, Japan
[6] Andrzej Mielecki Mem Independent Publ Clin Hosp, Katowice, Poland
[7] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[8] Sanofi, Chilly Mazarin, France
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2023年 / 188卷
关键词：
dupilumab; moderate-to-severe; hand; foot; dermatitis;
D O I：
10.1093/bjd/ljad162.029
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
408
引用
收藏
页数：2
相关论文
共 50 条
  • [31] OPTIMIZING TREATMENT WITH LURASIDONE IN PATIENTS WITH SCHIZOPHRENIA: RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
    Loebel, Antony
    Silva, Robert
    Goldman, Robert
    Watabbe, Kei
    Pikalov, Andrei
    Cucchiaro, Josephine
    Kane, John M.
    SCHIZOPHRENIA BULLETIN, 2015, 41 : S321 - S321
  • [32] Blackcurrant seed oil for prevention of atopic dermatitis in newborns: a randomized, double-blind, placebo-controlled trial
    Linnamaa, P.
    Savolainen, J.
    Koulu, L.
    Tuomasjukka, S.
    Kallio, H.
    Yang, B.
    Vahlberg, T.
    Tahvonen, R.
    CLINICAL AND EXPERIMENTAL ALLERGY, 2010, 40 (08): : 1247 - 1255
  • [33] A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, CROSSOVER TRIAL OF SYSTEMIC FLUNISOLIDE IN THE TREATMENT OF CHILDREN WITH SEVERE ATOPIC-DERMATITIS
    LAROSA, E
    MUSARRA, I
    RANNO, C
    MAIELLO, N
    NEGRI, L
    DELGIUDICE, MM
    OGGIANO, N
    KANTAR, A
    FABBRIZI, E
    BARBERIO, G
    PAJNO, GB
    CAVAGNI, G
    CAFFARELLI, C
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 1995, 56 (07): : 720 - 726
  • [34] Tralokinumab plus topical corticosteroids for the treatment of moderate-to-severe atopic dermatitis: results from the double-blind, randomized, multicentre, placebo-controlled phase III ECZTRA 3 trial
    Silverberg, J. I.
    Toth, D.
    Bieber, T.
    Alexis, A. F.
    Elewski, B. E.
    Pink, A. E.
    Hijnen, D.
    Jensen, T. N.
    Bang, B.
    Olsen, C. K.
    Kurbasic, A.
    Weidinger, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2021, 184 (03) : 450 - 463
  • [35] A randomized, double-blind, placebo-controlled, phase III trial of pregabalin in the treatment of patients with Fibromyalgia
    Mease, Philip J.
    Russell, I. Jon
    Arnold, Lesley M.
    Florian, Hana
    Young, James P.
    Martin, Susan A.
    Sharma, Uma
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (03) : 502 - 514
  • [36] Efficacy of House Dust Mite Sublingual Immunotherapy in Patients with Atopic Dermatitis: A Randomized, Double-Blind, Placebo-Controlled Trial
    Langer, Sarah Sella
    Cardili, Renata Nahas
    Lima Melo, Janaina Michelle
    Leme Ferriani, Mariana Paes
    Moreno, Adriana Santos
    Dias, Marina Mendonca
    Bueno-Filho, Roberto
    Candido Pocente, Renata Helena
    Roxo-Junior, Persio
    Silva, Jorgete
    Pereira Valera, Fabiana Cardoso
    Coelho, Eduardo Barbosa
    Santos Galvao, Clovis Eduardo
    Carmona, Fabio
    Aragon, Davi Casale
    Arruda, Luisa Karla
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2022, 10 (02): : 539 - +
  • [37] Dapoxetine for the Treatment of Premature Ejaculation: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 3 Trial in 22 Countries
    Buvat, Jacques
    Tesfaye, Fisseha
    Rothman, Margaret
    Rivas, David A.
    Giuliano, Francois
    EUROPEAN UROLOGY, 2009, 55 (04) : 957 - 968
  • [38] Neutralizing interleukin-13 increases skin microbial diversity: Results from a phase 3, randomized, double-blind, placebo-controlled trial with tralokinumab in adult patients with atopic dermatitis
    Bieber, Thomas
    Beck, Lisa A.
    Pink, Andrew
    Saeki, Hidehisa
    Eichenfield, Lawrence
    Werfel, Thomas
    Rosholm, Anders
    Ropke, Mads
    Paller, Amy
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB177 - AB177
  • [39] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Stephen K. Tyring
    Phoebe Rich
    Yayoi Tada
    Stefan Beeck
    Izabella Messina
    Jie Liu
    Xiaohong Huang
    Stephen Shumack
    Dermatology and Therapy, 2023, 13 : 595 - 608
  • [40] Risankizumab in Patients with Moderate-to-Severe Atopic Dermatitis: A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study
    Tyring, Stephen K. K.
    Rich, Phoebe
    Tada, Yayoi
    Beeck, Stefan
    Messina, Izabella
    Liu, Jie
    Huang, Xiaohong
    Shumack, Stephen
    DERMATOLOGY AND THERAPY, 2023, 13 (02) : 595 - 608
12345